Current location:health >>
Lilly rides Mounjaro, Zepbound to better
health989People have gathered around
IntroductionRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, ...
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Culture Chronicle news portal”。http://faroeislands.whychurchofchrist.com/html-60f899044.html
Related articles
Workers' paychecks grew faster in the first quarter, a possible concern for the Fed
healthWASHINGTON (AP) — Pay and benefits for America’s workers grew more quickly in the first three months ...
【health】
Read moreShopping trend takes retail sector by storm
healthAlthough fewer and fewer actual customers visit Sun Zhang's convenience stores, he is still going ga ...
【health】
Read moreHow China's new energy competitiveness becomes its new sin
healthBEIJING/LONDON, April 12 (Xinhua) -- As an old Chinese saying goes, "A common man is not guilty, but ...
【health】
Read more
Popular articles
- Family appeals ruling that threw out lawsuit over 2017 BIA shooting death in North Dakota
- Spring flower season boosts tourism industry in Hanzhong, NW China
- Vision China highlights crucial role of science and technology
- Scenery of Band
- Coleen Rooney gives a glimpse into her £20million Cheshire mansion as she employs a celebrity
- Inbound tour orders from 6 EU nations rise
Latest articles
LINKS
- Dune: Part Two review
- Rustle these up with Rosemary: Carrot cake with orange buttercream and walnuts
- Sydney Mardi Gras asks police not take part in Saturday's parade
- Ashley Roberts puts on a leggy display in a tiny mini
- Masterful meals: Pea and white truffle soup with Parmesan galettes
- King Willem
- ESTHER RANTZEN: I asked Mail readers to help me plan my funeral. Your choices
- Core blimey: Poached pears with blackberry drizzle and hazelnut shortbread
- Queen Camilla praises Kate Middleton
- US targets Russia with hundreds of sanctions over Ukraine war, Navalny death